Roche Signs $2.8 Billion Alnylam Deal for Hypertension Drug
Roche Holding AG will work together with Alnylam Pharmaceuticals Inc. on a potential treatment for high blood pressure
2023-07-24 16:49
How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:46
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20